contour pva embolization particles (Boston Scientific Corporation)
Structured Review
Contour Pva Embolization Particles, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/contour+pva+embolization+particles/contour+pva+embolization+particles/pmc11748381-35-19-23
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Middle meningeal artery embolization for recurrent subdural hematoma in an extra-intracranial anastomosis patient on anticoagulant medication: A case report Article Snippet: Initially, the dorsal branch of the MMA was embolized with polyvinyl-alcohol particles of the size 150 to 250 μm ( Article Title: Extended Right Hepatectomy following Clearance of the Left Liver Lobe and Portal Vein Embolization for Curatively Intended Treatment of Extensive Bilobar Colorectal Liver Metastases: A Single-Center Case Series Article Snippet: Transhepatic PVE procedures were performed by an experienced interventional radiologist using Contour PVA Embolization Particles in combination with Article Title: A retrospective cohort study comparing a novel, spherical, resorbable particle against five established embolic agents for uterine fibroid embolisation. Article Snippet: Embolic agents (used concurrently) included in the study were: Gel-bead (Teleflex, Wayne, Pennsylvania, United States); Embosphere Microspheres (Merit Medical Systems, South Jordan, Utah, United States); Article Title: Combined chemoembolization and thermal ablation for the treatment of metastases to the liver. Article Snippet: Purpose: The purpose of the study was to evaluate safety, time to recurrence, and overall survival (OS) in patients with liver metastases (LM), treated with transarterial chemoembolization (TACE) followed by ablation.. Materials and methods: This retrospective study included all patients with LM treated with combined TACE and ablation from August 1998 to September 2015.. Fortytwo patients (12 women, 30 men; age 62.9 ± 11.9 years) were treated for 44 LMs. Article Title: A retrospective cohort study comparing a novel, spherical, resorbable particle against five established embolic agents for uterine fibroid embolisation. Article Snippet: For Article Title: Aggressive giant dumbell-shaped thoracic vertebral hemangioma: illustrative case Article Snippet: Once a wedged position was reached and no backflow was recognized, |

